UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:	June 12, 2017 4:30 P.M.

Form:	S-3
CIK: 0001566373 Company Name: Spring Bank Pharmaceuticals, Inc. File Number: 333-218399